Anti-CADM-140 Antibody-positive Juvenile Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Cardiac Involvement

被引:22
|
作者
Sakurai, Nodoka [1 ]
Nagai, Kazushige [1 ]
Tsutsumi, Hiroyuki [1 ]
Ichimiya, Shingo [2 ]
机构
[1] Sapporo Med Univ, Sch Med, Dept Pediat, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
[2] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
关键词
POLYMYOSITIS;
D O I
10.3899/jrheum.101220
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:963 / 965
页数:3
相关论文
共 50 条
  • [21] Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome
    Tanaka, Nao
    Terao, Chikashi
    Nakayama, Yoichi
    Sasai, Tsuneo
    Umezawa, Natsuka
    Yagyu, Yuriko
    Ito, Kanae
    Koike, Ryuji
    Nakashima, Ran
    Hatta, Kazuhiro
    Mizoguchi, Fumitaka
    RHEUMATOLOGY, 2021, 60 (03) : E104 - E106
  • [22] Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease
    Fujimoto, Noriki
    Honda, Shinichiro
    Wakabayashi, Makiko
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Tanaka, Toshihiro
    MODERN RHEUMATOLOGY, 2016, 26 (04) : 614 - 616
  • [23] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    Ho So
    Victor Tak Lung Wong
    Virginia Weng Nga Lao
    Hin Ting Pang
    Ronald Man Lung Yip
    Clinical Rheumatology, 2018, 37 : 1983 - 1989
  • [24] Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
    Sakamoto, Noriho
    Ishimoto, Hiroshi
    Nakashima, Shota
    Yura, Hirokazu
    Miyamura, Takuto
    Okuno, Daisuke
    Hara, Atsuko
    Kitazaki, Takeshi
    Kakugawa, Tomoyuki
    Ishimatsu, Yuji
    Satoh, Minoru
    Mukae, Hiroshi
    INTERNAL MEDICINE, 2019, 58 (06) : 837 - 841
  • [25] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    So, Ho
    Wong, Victor Tak Lung
    Lao, Virginia Weng Nga
    Pang, Hin Ting
    Yip, Ronald Man Lung
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
  • [26] A Fatal Case of Anti-MDA5 Antibody Positive Clinically Amyopathic Dermatomyositis (CADM) Associated with Rapidly Progressive Interstitial Lung Disease
    Mohammed, A.
    Torres, C.
    AlNabulsi, M.
    Smith, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
    Kentaro Nishi
    Masao Ogura
    Naotaka Tamai
    Masafumi Gima
    Kentaro Ide
    Goro Koinuma
    Koichi Kamei
    Shuichi Ito
    Pediatric Rheumatology, 20
  • [28] Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
    Nishi, Kentaro
    Ogura, Masao
    Tamai, Naotaka
    Gima, Naofumi
    Ide, Kentaro
    Koinuma, Goro
    Kamei, Koichi
    Ito, Shuichi
    PEDIATRIC RHEUMATOLOGY, 2022, 20 (01)
  • [29] Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis
    Wongjirattikarn, Rachot
    Chaowattanapanit, Suteeraporn
    Choonhakarn, Charoen
    So-ngern, Apichart
    Mahakkanukrauh, Ajanee
    Foocharoen, Chingching
    CASE REPORTS IN DERMATOLOGY, 2020, 12 (01): : 57 - 63
  • [30] Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung disease
    Hata, Kenichiro
    Kotani, Takuya
    Matsuda, Shogo
    Fujiki, Youhei
    Suzuka, Takayasu
    Kiboshi, Takao
    Wada, Yumiko
    Shiba, Hideyuki
    Shoda, Takeshi
    Kagitani, Maki
    Takeuchi, Tohru
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)